PAIN RESEARCH,
Journal Year:
2022,
Volume and Issue:
37(2), P. 89 - 96
Published: July 15, 2022
Non–coding
RNAs,
including
microRNA
and
lncRNA,
affect
various
cellular
functions
primarily
by
regulating
diverse
stages
of
gene
expression,
such
as
transcription,
translation,
epigenetic
modulation.
In
recent
years,
it
has
been
shown
that
many
non–coding
RNAs
are
dysregulated
in
pain
disorders
can
be
a
potential
therapeutic
target.
Intriguingly,
part
encapsulated
extracellular
vesicles
abundantly
released
into
the
space.
These
taken
up
nearby
or
even
distant
cells
exert
their
own
functions,
indicating
they
act
important
mediators
cell–cell
communication.
fact,
some
microRNAs
have
to
cause
hyperalgesia
acting
neurons
immune
cells.
addition,
blood
cerebrospinal
fluid
expected
biomarker
for
purposes,
diagnosis,
drug
responsiveness
prediction
prognosis,
disorders.
this
review,
we
summarize
current
insights
significance
RNA
treatment.
Gut Microbes,
Journal Year:
2023,
Volume and Issue:
16(1)
Published: Dec. 18, 2023
Diarrhea-predominant
irritable
bowel
syndrome
(IBS-D),
associated
with
increased
intestinal
permeability,
inflammation,
and
small
bacterial
overgrowth,
can
be
triggered
by
acute
gastroenteritis.
Cytolethal
distending
toxin
B
(CdtB)
is
produced
gastroenteritis-causing
pathogens
may
underlie
IBS-D
development,
through
molecular
mimicry
vinculin.
Here,
we
examine
the
effects
of
exposure
to
CdtB
alone
on
gut
microbiome
composition,
host
gene
expression,
IBS-D-like
phenotypes
in
a
rat
model.
CdtB-inoculated
rats
exhibited
anti-CdtB
levels,
which
correlated
stool
wet
weights,
pro-inflammatory
cytokines
(TNFα,
IL2)
predicted
microbial
metabolic
pathways
including
inflammatory
responses,
TNF
diarrhea.
Three
distinct
ileal
profiles
(microtypes)
were
identified
rats.
The
first
microtype
(most
like
controls)
had
altered
relative
abundance
(RA)
genera
Bifidobacterium,
Lactococcus,
Rothia.
second
lower
diversity,
higher
Escherichia-Shigella
RA,
absolute
E.
coli
abundance,
tissue
expression
immune-response
TNF-response
genes
compared
controls.
third
RA
hydrogen
sulfide
(H2S)-producer
Desulfovibrio,
H2S-associated
pain/serotonin
response
genes.
All
decreased
cell
junction
component
mRNAs,
vinculin-associated
proteins.
Significantly,
cluster-specific
microRNA-mRNA
interactions
controlling
visceral
hypersensitivity/pain,
gastrointestinal
motility
genes,
several
previously
IBS
seen.
These
findings
demonstrate
that
results
IBS-like
inflammation
diarrhea-like
stool,
barrier
components,
microtypes
influenced
changes
microRNA-modulated
consistent
specific
symptoms.
Annals of Translational Medicine,
Journal Year:
2022,
Volume and Issue:
11(2), P. 34 - 34
Published: Dec. 22, 2022
Irritable
bowel
syndrome
(IBS)
is
a
common
gastrointestinal
disease.
Emerging
studies
have
demonstrated
that
microRNAs
(miRNAs)
are
commonly
dysregulated
in
patients
with
IBS,
and
aberrant
miRNAs
implicated
IBS
occurrence.
Although
miR-155-5p
participates
inflammatory
disease
(IBD)
intestinal
barrier
dysfunction,
the
role
of
unclear.In
present
study,
colon
samples
were
obtained
from
mice
induced
by
trinitrobenzenesulfonic
acid
(TNBS),
levels
miR-155-5p,
claudin-1
(CLDN1),
zonula
occludens-1
(ZO-1)
assessed
using
quantitative
real-time
polymerase
chain
reaction
(qRT-PCR)
immunohistochemical
analysis.
The
regulatory
CLDN1
ZO-1
expression
was
validated
dual
luciferase
reporter
assay.We
found
upregulated
compared
healthy
subjects
normal
mice,
respectively.
Meanwhile,
decreased
mice.
Importantly,
forced
inhibited
expression.
In
intraperitoneal
injection
inhibitor
increased
mucosal
epithelium,
enhanced
visceral
response
thresholds,
myeloperoxidase
(MPO)
activity.In
summary,
these
results
suggested
participated
pathogenesis
at
least
part
inhibiting
expression,
indicating
may
be
potential
therapeutic
target
for
IBS.
Frontiers in Pharmacology,
Journal Year:
2023,
Volume and Issue:
14
Published: March 16, 2023
Background
and
objective:
IBS-D
is
a
common
functional
bowel
disease
with
complex
etiology
without
biomarker.
The
pathological
physiological
basis
of
focuses
on
visceral
hypersensitivity.
However,
its
epigenetic
mechanism
remains
elusive.
Our
study
aimed
to
integrate
the
relationship
between
differentially
expressed
miRNAs,
mRNAs
proteins
in
patients
order
reveal
hypersensitivity
from
transcription
protein
levels
provide
molecular
for
discovering
biomarkers
IBS-D.
Methods:
intestinal
biopsies
healthy
volunteers
were
obtained
high-throughput
sequencing
miRNAs
mRNAs.
differential
selected
verified
by
q-PCR
experiment
followed
target
mRNA
prediction.
Biological
functions
respectively
analyzed
mRNAs,
previously
identified
explore
characteristic
involved
At
last,
interaction
analysis
was
performed
regulation
levels.
Results:
Thirty-three
found
be
five
them
further
confirmed,
including
upregulated
hsa-miR-641,
hsa-miR-1843,
hsa-let-7d-3p
downregulated
hsa-miR-219a-5p,
hsa-miR-19b-1-5p.
In
addition,
3,812
identified.
Thirty
intersecting
molecules
Fourteen
proteins,
thirty-six
different
According
integrated
miRNA-mRNA-protein,
we
noticed
two
new
COPS2
regulated
hsa-miR-19b-1-5p
MARCKS
hsa-miR-641.
Meanwhile
some
critical
signaling
pathways
such
as
MAPK,
GABAergic
synapse,
Glutamatergic
Adherens
junction.
Conclusion:
expressions
hsa-let-7d-3p,
tissues
significantly
different.
Moreover,
they
could
regulate
variety
pathways,
which
multifaceted
multilevel
Journal of Gastrointestinal and Liver Diseases,
Journal Year:
2023,
Volume and Issue:
32(2), P. 230 - 240
Published: June 22, 2023
Irritable
bowel
syndrome
(IBS)
is
a
common
chronic
functional
gastrointestinal
disorder
defined
by
disturbances
in
habits
and
abdominal
pain,
the
absence
of
known
organic
pathology
that
affects
between
5
to
10%
healthy
populations.
Despite
improvements
detection
treatment,
pathogenesis
IBS
has
not
been
clarified.
Several
microRNAs
(miRNAs)
are
involved
through
increased
intestinal
permeability,
inflammation,
modulation
visceral
hyperalgesia,
they
may
have
potential
be
used
as
biomarkers
therapeutic
targets.
Here,
we
summarized
recent
advances
about
role
miRNAs
development
symptoms
possibility
use
them
targets
mitigate
IBS.
Biomedicines,
Journal Year:
2023,
Volume and Issue:
11(8), P. 2235 - 2235
Published: Aug. 9, 2023
Short
non-coding
RNAs,
miRNAs,
play
roles
in
the
control
of
cell
growth
and
differentiation
cancer.
Reportedly,
introduction
miRNAs
could
reduce
biologically
malignant
behavior
cancer
cells,
suggesting
a
possible
use
as
therapeutic
reagents.
Given
that
forced
expression
several
including
miR-302,
results
cellular
reprograming
human
mouse
which
is
similar
to
effects
transcription
factors
Oct4,
Sox2,
Klf4,
c-Myc,
this
suggests
selective
will
be
able
achieve
anti-cancer
at
epigenetic
metabolic
levels.
In
review
article,
we
bring
together
recent
advances
made
studies
microRNA-based
approaches
therapy-resistant
cancers,
especially
gastrointestinal
organs.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 19, 2024
Irritable
bowel
syndrome
(IBS)
is
a
common
gastrointestinal
disease.
Recently,
an
increasing
number
of
studies
have
shown
that
Toll-like
receptor
4
(TLR4),
widely
distributed
on
the
surface
variety
epithelial
cells
(ECs)
and
immune
sentinel
in
gut,
plays
vital
role
developing
IBS.
PLoS ONE,
Journal Year:
2024,
Volume and Issue:
19(12), P. e0313106 - e0313106
Published: Dec. 31, 2024
Background
Recently
researches
have
reported
that
miRNA
and
its
target
genes
are
associated
with
osteoporosis.
MiRNA
mRNA
might
be
potential
diagnostic
markers
for
Purposes
The
aim
of
this
study
is
to
explore
the
by
bioinformatics
method
clinical
analysis.
Patients
methods
expression
profiles
were
obtained
from
GSE74209,
GSE64433
GSE115773
in
Gene
Omnibus
(GEO).
GSE100609.
Wayne
intersection
used
different
expressed
miRNAs
(DE-miRs).
Select
highest
Fold
Change
subsequent
research.
Screening
using
TargetScan
miRDB
tools.
GO
KEGG
analyses
(TGs)
function
performed.
Validate
selected
TGs
We
collected
female
patients
femural
intertrochanteric
fractures
July
1,
2023
October
31,
2023.
Patient’s
bone
marrow
data
collected.
differentially
verified
through
RT-qPCR.
All
subjected
Shapiro-Wilk
test.
Using
Pearson
or
Spearman
test
detect
correlation
between
various
indicators,
then
incorporating
indicators
related
density
into
multiple
linear
regression
equations.
Partial
analysis
was
analyze
final
density.
Results
A
total
140
DE-miRs
identified.
Set
fold
change
“>1”
ultimately
include
5
miRNAs.
miR-595
(highest
|log
2
FC|)
as
subject
3542
targeted
mRNAs
predicted
362
miRDB.
337
intersected,
which
mainly
enriched
nucleus.
Only
Cldnd1
identified
GSE100609
dataset.
found
highly
high
mass,
while
downregulated.
There
a
strong
collinearity
Cldnd1.
Further
showed
Conclusions
These
suggest
factors
decreased
mass.